NYSE American - Nasdaq Real Time Price USD

OS Therapies Incorporated (OSTX)

Compare
1.5300
+0.0900
+(6.34%)
As of 2:23:50 PM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Expense
6,813.8460
6,813.8460
4,342.6470
4,446.2990
4,837.3550
Operating Income
-6,813.8460
-6,813.8460
-4,342.6470
-4,446.2990
-4,837.3550
Net Non Operating Interest Income Expense
-2,051.8390
-2,051.8390
-3,448.9370
-1,808.3860
-2,582.8930
Other Income Expense
-17.2530
-17.2530
--
--
--
Pretax Income
-8,882.9380
-8,882.9380
-7,791.5840
-6,254.6850
-7,420.2480
Net Income Common Stockholders
-10,886.1630
-10,886.1630
-7,916.5840
-6,379.6850
-7,513.9980
Diluted NI Available to Com Stockholders
-10,886.1630
-10,886.1630
-7,916.5840
-6,379.6850
-7,513.9980
Basic EPS
-0.88
--
-0.38
-0.32
-0.33
Diluted EPS
-0.88
--
-0.38
-0.32
-0.33
Basic Average Shares
12,377.2990
--
20,597.7770
23,100.8190
23,100.8190
Diluted Average Shares
12,377.2990
--
20,597.7770
23,100.8190
23,100.8190
Total Operating Income as Reported
-6,813.8460
-6,813.8460
-4,342.6470
-4,446.2990
-4,837.3550
Total Expenses
6,813.8460
6,813.8460
4,342.6470
4,446.2990
4,837.3550
Net Income from Continuing & Discontinued Operation
-8,882.9380
-8,882.9380
-7,791.5840
-6,254.6850
-7,420.2480
Normalized Income
-8,882.9380
-8,882.9380
-7,791.5840
-6,254.6850
-7,420.2480
Interest Income
--
--
0.0020
--
--
Interest Expense
2,051.8390
2,051.8390
3,448.9390
1,808.3860
2,582.8930
Net Interest Income
-2,051.8390
-2,051.8390
-3,448.9370
-1,808.3860
-2,582.8930
EBIT
-6,831.0990
-6,831.0990
-4,342.6450
-4,446.2990
-4,837.3550
EBITDA
-6,828.3190
-6,828.3190
-4,338.4250
-4,445.4940
-4,836.5500
Reconciled Depreciation
2.7800
2.7800
4.2200
0.8050
0.8050
Net Income from Continuing Operation Net Minority Interest
-8,882.9380
-8,882.9380
-7,791.5840
-6,254.6850
-7,420.2480
Normalized EBITDA
-6,828.3190
-6,828.3190
-4,338.4250
-4,445.4940
-4,836.5500
12/31/2021 - 8/1/2024

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ELDN Eledon Pharmaceuticals, Inc.
3.0000
-0.33%
 
CUE Cue Biopharma, Inc.
0.7200
-10.00%
 
SNGX Soligenix, Inc.
2.0273
+1.36%
 
GLMD Galmed Pharmaceuticals Ltd.
1.3100
-7.09%
 
DTIL Precision BioSciences, Inc.
5.10
-7.64%
 
BDRX Biodexa Pharmaceuticals Plc
1.4400
-1.38%
 
CERO CERo Therapeutics Holdings, Inc.
0.5770
-1.37%
 
ANIX Anixa Biosciences, Inc.
2.6901
-5.61%
 
EVAX Evaxion Biotech A/S
1.3050
-4.74%
 
ADTX Aditxt, Inc.
2.2000
-8.71%